Advanced Biopolymers

Biopolymers, the most promising of which is Polylactide (PLA), are a type of plastic which, instead of being manufactured from petrochemicals, are made from sustainable feedstock’s such as sugar, starch or Cellulose. Till date, the use of biopolymers, including first generation PLA, has been limited by their Physical properties and relatively high cost of manufacture. Next generation biopolymers, including Plastic component fabrication, Polysaccharides second generation PLA, are expected to be cheaper and to offer improved performance and a wider application reach, enabling them to capture an increasing share of the various markets for Biopolymers. Innovations has already achieved significant success with its early investments its £1.5m investment in obesity drug developer  return up to £22m, following its sale for£100m in 2013, while the sale of Respivert, a small molecule drug discovery company, resulted in Innovations realizing £9.5m, a 4.7 return on investment. In the year to2015, Innovations invested £14.0m in 20 ventures, helping to launch three new companies.

Biopolymers are polymers that occur in nature for example Carbohydrates and proteins.  Biopolymers are already being produced commercially on large scales, although they usually are not used for the production of plastics. Even if only a small percentage of the biopolymers already being produced were used in the production of plastics, it would significantly decrease our dependence on manufactured, non-renewable resources.

  • Chemistry of biopolymers
  • Polylactic acid in Biopolymers
  • Nucleic acids in Biopolymers
  • Polysaccharides in Biopolymers
  • Polynucleotide in Biopolymers
  • Automotive Applications
  • Catalysis by polymer-metal complexes

Advanced Biopolymers Conference Speakers